References
- Eisenhauer E A, Ten Bokkel Huinink W W, Swenerton K D, et al. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion. J Clin Oncol 1994; 12: 2654–2666
- Omura G A, Brady M F, Delmore J E, et al. A randomized trial of paclitaxel at 2 dose levels and filgrastim at 2 doses in platinum pretreated epithelial ovarian cancer: A Gynecologic Oncology Group, SWOG, NCCTG and ECOG study. Proc Am Soc Clin Oncol 1996; 15: 280, (abstract)
- Rowinsky E K, Mackey M K, Goodman S N. Meta analysis of paclitaxel dose-response and dose-intensity in recurrent or refractory ovarian cancer. Proc Am Soc Clin Oncol 1996; 15: 284, (abstract)
- Gore M E, Mainwaring P N, Macfarlane V, et al. A randomized study of high versus standard dose carboplatin in patients with advanced epithelial ovarian cancer. Proc Am Soc Clin Oncol 1996; 15: 284, (abstract)
- Wrigley E, Weaver A, Jayson G, et al. A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: A comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervals. Ann Oncol 1996; 7: 705–711
- Conte P F, Bruzzone M, Carnino F, et al. High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: A randomized study of the Gruppo Oncologico Nord-Ovest. J Clin Oncol 1996; 14: 351–356
- Colombo N, Pittelli M R, Parma G, et al. Cisplatin dose intensity in advanced ovarian cancer: A randomized study of conventional dose vs dose-intense cisplatin monochemotherapy. Proc Am Soc Clin Oncol 1993; 12: 255, (abstract)
- Dittrich C, Obermair A, Kurz C, et al. Prospective randomized trial of cisplatin/carboplatin versus conventional cisplatin/cyclophosphamide in epithelial ovarian cancer: First results of the impact of platinum dose intensity on patient outcome. Proc Am Soc Clin Oncol 1996; 15: 279, (abstract)
- McGuire W P, Hoskins W J, Brady M F, et al. Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: A Gynecologic Oncology Group study. J Clin Oncol 1995; 13: 1589–1599
- Jakobsen A. A dose intensity study of carboplatin in ovarian cancer. Int J Gynecol Cancer 1995; 5: 11, (abstract)